These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 201324

  • 1. Characteristics of (-)-[3H]-dihydroalprenolol binding to beta-adrenoceptors on rat lung membranes [proceedings].
    Barnett DB, Nahorski SR, Rugg EL.
    Br J Pharmacol; 1977 Nov; 61(3):459P. PubMed ID: 201324
    [No Abstract] [Full Text] [Related]

  • 2. Pitfalls in the assessment of the specific binding of(-)[3H]-dihydroalprenolol to beta-adrenoceptors [proceedings].
    Nahorski SR, Richardson A.
    Br J Pharmacol; 1979 Jul; 66(3):469P-470P. PubMed ID: 230879
    [No Abstract] [Full Text] [Related]

  • 3. Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo.
    Baker SP, Pitha J.
    J Pharmacol Exp Ther; 1982 Feb; 220(2):247-51. PubMed ID: 6120224
    [Abstract] [Full Text] [Related]

  • 4. Binding of (3H)dihydroalprenolol to beta adrenoceptors of cells isolated from adult rat heart.
    Moustafa E, Giachetti A, Downey HF, Bashour FA.
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 303(1):107-9. PubMed ID: 209345
    [Abstract] [Full Text] [Related]

  • 5. [3H]dihydroalprenolol binding in the rat brainstem.
    Stone EA, U'Prichard DC.
    Eur J Pharmacol; 1981 Oct 22; 75(2-3):159-61. PubMed ID: 6119217
    [Abstract] [Full Text] [Related]

  • 6. Identity of [3H]-dihydroalprenolol binding sites and beta-adrenergic receptors coupled with adenylate cyclase in the central nervous system: pharmacological properties, distribution and adaptive responsiveness.
    Dolphin A, Adrien J, Hamon M, Bockaert J.
    Mol Pharmacol; 1979 Jan 22; 15(1):1-15. PubMed ID: 218089
    [No Abstract] [Full Text] [Related]

  • 7. Direct evidence of two types of beta adrenoceptor binding site in lung tissue.
    Barnett DB, Rugg EL, Nahorski SR.
    Nature; 1978 May 11; 273(5658):166-8. PubMed ID: 25391
    [No Abstract] [Full Text] [Related]

  • 8. Effects of phospholipids on the binding of [3H]dihydroalprenolol to the beta-adrenergic receptor of rabbit heart membranes.
    Thang NX, Borsodi A, Wollemann M.
    Biochem Pharmacol; 1980 Oct 15; 29(20):2791-7. PubMed ID: 6254538
    [No Abstract] [Full Text] [Related]

  • 9. In vivo receptor binding of iodinated beta-adrenoceptor blockers.
    Eckelman WC, Gibson RE, Vieras F, Rzeszotarski WJ, Francis B, Reba RC.
    J Nucl Med; 1980 May 15; 21(5):436-42. PubMed ID: 6103024
    [Abstract] [Full Text] [Related]

  • 10. Mapping of mammalian beta-adrenoreceptors by use of macromolecular alprenolol derivatives. A comparison with amphibian erythrocyte receptors.
    Kusiak JW, Pitha J.
    Biochem Pharmacol; 1982 Jun 01; 31(11):2071-6. PubMed ID: 6180753
    [Abstract] [Full Text] [Related]

  • 11. Identification and characterization of beta-adrenergic receptors in rat parotid membranes.
    Au DK, Malbon CC, Butcher FR.
    Biochim Biophys Acta; 1977 Dec 22; 500(2):361-71. PubMed ID: 201297
    [No Abstract] [Full Text] [Related]

  • 12. (+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes.
    U'Prichard DC, Bylund DB, Snyder SH.
    J Biol Chem; 1978 Jul 25; 253(14):5090-102. PubMed ID: 209026
    [Abstract] [Full Text] [Related]

  • 13. Homogeneity of beta 2-adrenoceptors on rat erythrocytes and reticulocytes. A comparison with heterogeneous rat lung beta-adrenoceptors.
    Dickinson K, Richardson A, Nahorski SR.
    Mol Pharmacol; 1981 Mar 25; 19(2):194-204. PubMed ID: 6112660
    [No Abstract] [Full Text] [Related]

  • 14. Methodological aspects of receptor research: problems in the assessment of specific and non-specific binding of 3H-dihydroalprenolol to bovine lung membranes.
    Richardson A, Nahorski SR.
    Eur J Respir Dis Suppl; 1984 Mar 25; 135():114-23. PubMed ID: 6329797
    [Abstract] [Full Text] [Related]

  • 15. beta-adrenergic receptors in brown adipose tissue: identification by (-)[3H]dihydroalprenolol binding.
    Bukowiecki LJ, Caron MG, Vallieres J, LeBlanc J.
    Experientia Suppl; 1978 Mar 25; 32():55-9. PubMed ID: 206459
    [No Abstract] [Full Text] [Related]

  • 16. Binding of 3H-dihydroalprenolol to beta-adrenoceptors in adipocytes of spontaneously hypertensive rats and essentially hypertensive patients.
    Boriskina GM, Postnov YuV.
    Experientia; 1982 Feb 15; 38(2):263-4. PubMed ID: 6277685
    [No Abstract] [Full Text] [Related]

  • 17. Associations of [3H]dihydroalprenolol with biological membranes.
    Mendel CM, Almon RR.
    Gen Pharmacol; 1979 Feb 15; 10(1):31-40. PubMed ID: 33101
    [No Abstract] [Full Text] [Related]

  • 18. Beta-adrenergic receptors in early human placenta characterization of [3H]-dihydroalprenolol binding.
    Falkay G, Kovacs L.
    Life Sci; 1983 Apr 04; 32(14):1583-90. PubMed ID: 6300586
    [Abstract] [Full Text] [Related]

  • 19. Beta-adrenoceptors of human lymphocytes: decrease in affinity of agonist for (-)3h-dihydroalprenolol binding sites by cytoplasmic fractions.
    Watanabe Y, Lai RT, Higuchi H, Maeda H, Yoshida H.
    Life Sci; 1981 Mar 23; 28(12):1399-405. PubMed ID: 6264246
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of beta-adrenoceptors in bovine intracerebral microvessels and cerebral grey matter by [3H]dihydroalprenolol binding.
    Culvenor AJ, Jarrott B.
    Neuroscience; 1981 Mar 23; 6(8):1643-8. PubMed ID: 6267511
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.